Comparison of ELISA-and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis S De Meyer, JM Schaeverbeke, IMW Verberk, B Gille, M De Schaepdryver, ... Alzheimer's research & therapy 12, 1-16, 2020 | 65 | 2020 |
Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer’s disease D Shah, W Gsell, J Wahis, ES Luckett, T Jamoulle, B Vermaercke, ... Cell reports 40 (8), 2022 | 51 | 2022 |
Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults JM Schaeverbeke, S Gabel, K Meersmans, ES Luckett, S De Meyer, ... Alzheimer's Research & Therapy 13, 1-16, 2021 | 26 | 2021 |
Analysis of psychological symptoms following disclosure of amyloid–positron emission tomography imaging results to adults with subjective cognitive decline C Caprioglio, F Ribaldi, LNC Visser, C Minguillon, LE Collij, ... JAMA network open 6 (1), e2250921-e2250921, 2023 | 11 | 2023 |
Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease S De Meyer, J Vanbrabant, JM Schaeverbeke, M Reinartz, ES Luckett, ... Annals of clinical and translational neurology 9 (5), 734-746, 2022 | 11 | 2022 |
Changes in the language system as amyloid-β accumulates M Reinartz, S Gabel, J Schaeverbeke, K Meersmans, K Adamczuk, ... Brain 144 (12), 3756-3768, 2021 | 9 | 2021 |
Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration S Chatterjee, M Sealey, E Ruiz, CM Pegasiou, K Brookes, S Green, ... Plos one 18 (1), e0262792, 2023 | 8 | 2023 |
clinical effect of early vs late amyloid positron emission tomography in memory clinic patients: the AMYPAD-DPMS randomized clinical trial D Altomare, F Barkhof, C Caprioglio, LE Collij, P Scheltens, IL Alves, ... JAMA neurology 80 (6), 548-557, 2023 | 7 | 2023 |
Association of Alzheimer’s disease polygenic risk scores with amyloid accumulation in cognitively intact older adults ES Luckett, Y Abakkouy, M Reinartz, K Adamczuk, J Schaeverbeke, ... Alzheimer's Research & Therapy 14 (1), 138, 2022 | 7 | 2022 |
Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth M Reinartz, ES Luckett, J Schaeverbeke, S De Meyer, K Adamczuk, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (11), 3772-3786, 2022 | 4 | 2022 |
Longitudinal changes in 18F-flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: methodological considerations ES Luckett, J Schaeverbeke, S De Meyer, K Adamczuk, K Van Laere, ... NeuroImage: Clinical 37, 103321, 2023 | 3 | 2023 |
Lack of association between bridging integrator 1 (BIN1) rs744373 polymorphism and tau‐PET load in cognitively intact older adults J Schaeverbeke, ES Luckett, S Gabel, M Reinartz, S De Meyer, I Cleynen, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 8 (1 …, 2022 | 3 | 2022 |
Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes S De Meyer, ER Blujdea, J Schaeverbeke, M Reinartz, ES Luckett, ... Brain 147 (3), 936-948, 2024 | 2 | 2024 |
Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults ES Luckett, M Zielonka, A Kordjani, J Schaeverbeke, K Adamczuk, ... Alzheimer's Research & Therapy 15 (1), 121, 2023 | 1 | 2023 |
Serum biomarkers for prognosis and monitoring in asymptomatic Alzheimer’s Disease S De Meyer, R Blujdea, J Schaeverbeke, M Reinartz, ES Luckett, ... Alzheimer's & Dementia 19, e074015, 2023 | | 2023 |
Differential associations between regional amyloid PET and Alzheimer’s disease polygenic risk scores ES Luckett, LE Collij, L Lorenzini, N Tesi, N Vilor‐Tejedor, DV García, ... Alzheimer's & Dementia 19, e071266, 2023 | | 2023 |
Longitudinal changes in amyloid, polygenic risk, and gene expression to profile asymptomatic Alzheimer’s disease E Luckett, R Vandenberghe, P Dupont, I Cleynen | | 2023 |
Weighted gene co-expression network analysis detects changes in the peripheral blood transcriptome in asymptomatic alzheimer’s disease E Luckett, A Kordjani, J Schaeverbeke, K Adamczuk, S De Meyer, ... International Conference on Alzheimer's and Parkinson's Diseases and related …, 2023 | | 2023 |
Whole-blood RNA sequencing detects changes in the peripheral blood transcriptome in asymptomatic Alzheimer’s disease E Luckett, M Zielonka, A Kordjani, J Schaeverbeke, K Adamczuk, ... Catalysing a United Response in Europe to Neurodegenerative Diseases, Date …, 2023 | | 2023 |
Future amyloid accumulation status affects the preservation of peripheral whole-blood gene co-expression networks in asymptomatic Alzheimer’s disease E Luckett Human Amyloid Imaging, Location: Miami, 2023 | | 2023 |